Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342549 · ClinicalTrials.gov registry record · Phase 3
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
A Phase 3 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 3
- Development phase
- 62
- Enrollment target
NCT01342549: Completed Phase 3 study, sponsored by VA Office of Research and Development.
NCT01342549 is a Phase 3 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01342549, a Phase 3 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand the effectiveness of valproate (a common mood stabilizer) to further reduce alcohol misuse when given in addition to attending an alcohol rehabilitation program as well as the treatment of mood disorders or PTSD. The main goal of this project is to understand if people receiving valproate will have a better recovery than people receiving the standard treatment for alcohol dependence: naltrexone.
Interventions
- DRUG Valproate
- DRUG Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01342549
The ClinicalTrials.gov registry entry for NCT01342549 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Valproate is the first listed.
NCT01342549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01342549 about?
NCT01342549 is a clinical study titled "Treatment Strategy for Alcohol Use Disorders in Veterans With TBI". The purpose of this research study is to understand the effectiveness of valproate (a common mood stabilizer) to further reduce alcohol misuse when given in addition to attending an alcohol rehabilitation program as well as the treatment of mood disorders or PTSD. The main goal of this project is to...
What is the current status of trial NCT01342549?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 62 participants. The study started on 2011-09. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01342549?
The interventions under investigation include: Valproate (DRUG), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT01342549?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.